Clinical Trial Update: The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating nasal administration of carbon dioxide (CO2) for symptomatic relief in seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Nasal Carbon Dioxide (CO2) (carbon dioxide)

Snippet

Sponsor: Capnia, Inc. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED